Can Ribavirin be Avoided in the Management of Hepatitis C Genotype 3 Patients When Treated With Direct Acting Antivirals? A Systematic Review and Meta-Analysis Khan, M., Cholankeril, G., Gadiparthi, C., Siddiqui, M., Haq, K. F., Hahambis, T., Ahmed, A. NATURE PUBLISHING GROUP. 2017: S559–S560

View details for Web of Science ID 000439259002231